PIPELINE

Pipeline

Abarceo Pharma AB

Medeon Science Park
Per Albin Hanssons vä 41, 205 12
Malmö, Sweden

Email: info@abarceo.com

Abarceo Pharma is a Lund University Holding company and was founded in December 2017 by Scientific founders Prof. Claes Wollheim, MD, and Associate Prof. Albert Salehi. The company is dedicated to developing novel therapeutics for type-2 diabetes based upon a deep molecular and genetic understanding of the disease.